Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Last week, Medtronic announced the intent to separate its diabetes business into a new standalone company. The new company, which remains unnamed, is expected to launch within 18 months.

CNW/ -- (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Medtronic, which announced last month it will spin off its $2.8 billion diabetes unit as a standalone public company, has ...

Image courtesy of Medtronic] The soon-to-be-separated Medtronic (NYSE: MDT) + Diabetes unit has a new — yet familiar — name, ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

Deal Overview On May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...